Genetic Testing Experiences of People Living with Inherited Retinal Degenerations: Results of a Global Survey.

Introduction: Obtaining a genetic diagnosis via genetic testing (GT) is a fundamental step in determining the eligibility of a patient to be enrolled in emerging clinical trials and research studies. Besides, the knowledge of genetic outcome allows patients to plan for significant life choices. However, critical barriers exist to an equitable access to genetic services globally.

Evaluation of exercise on individuals with dementia and their carers: a randomised controlled trial.

Background: Almost all of the 820,000 people in the UK with dementia will experience Behavioural and Psychological Symptoms of Dementia (BPSD). However, research has traditionally focused on treating cognitive symptoms, thus neglecting core clinical symptoms that often have a more profound impact on living with dementia. Recent evidence (Kales et al, 2007; Ballard et al, 2009) indicates that the popular approach to managing BPSD - prescription of anti-psychotic medication - can increase mortality and the risk of stroke in people with dementia as well as impair quality of life and accelerate cognitive decline.

Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study.

Purpose: Dactinomycin (actinomycin D) is an antitumor antibiotic used routinely to treat certain pediatric and adult cancers. Despite concerns over the incidence of toxicity, little is known about the pharmacology of dactinomycin. A study was done to investigate dactinomycin pharmacokinetics in children.

Pharmacokinetically guided dosing of carboplatin in paediatric cancer patients with bilateral nephrectomy.

An approach to carboplatin dosing in children with bilateral nephrectomy using a renal function-based dosing formula with a glomerular filtration rate of zero was investigated in the current study. Carboplatin exposure was determined in a total of nine courses of chemotherapy in four patients with Wilms' tumour. Carboplatin exposures following initial dosing were less than 50% of the defined target area under the plasma concentration-time curve (AUC) in all four patients studied, with actual AUC values of between 31% and 45% of the target exposures.

Magnesium iodide-4,4'-bipyridine-water (1/3/4) and strontium iodide-4,4'-bipyridine-propan-1-ol (1/2.5/2).

Both of the title compounds, catena-poly[[[tetraaquamagnesium(I)]-micro-4,4'-bipyridine-kappa(2)N:N'] diiodide bis(4,4'-bipyridine) solvate], [[Mg(C(10)H(8)N(2))(H(2)O)(4)]I(2).2C(10)H(8)N(2)](n), (I), and catena-poly[[[micro-4,4'-bipyridine-bis[diiodobis(propan-1-ol)strontium(I)]]-di-micro-4,4'-bipyridine-kappa(4)N:N'] bis(4,4'-bipyridine) solvate], [[Sr(2)I(4)(C(10)H(8)N(2))(3)(C(3)H(8)O)(4)].2C(10)H(8)N(2)](n), (II), are one-dimensional polymers which are single- and double-stranded, respectively, the metal atoms being linked by the 4,4'-bipyridine moieties.